| Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer (NCT00507858) | M.D. Anderson Cancer Center | 2005-09-01 |
| Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma (NCT00101010) | M.D. Anderson Cancer Center | 2005-09-01 |
| Evaluation of the Bio-Seal Biopsy Track Plug (NCT00527722) | M.D. Anderson Cancer Center | 2005-09-01 |
| Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer (NCT00508144) | M.D. Anderson Cancer Center | 2005-09-01 |
| Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients (NCT00338039) | M.D. Anderson Cancer Center | 2005-09-01 |
| Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma (NCT00412581) | M.D. Anderson Cancer Center | 2005-09-01 |
| Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer (NCT00527982) | M.D. Anderson Cancer Center | 2005-09-01 |
| Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer (NCT00499512) | M.D. Anderson Cancer Center | 2005-08-10 |
| Measuring Sleep Disturbance Among Cancer Patients (NCT00505544) | M.D. Anderson Cancer Center | 2005-08-01 |
| Fatigue in Emergency Center Patients (NCT00504985) | M.D. Anderson Cancer Center | 2005-08-01 |
| Gastrointestinal Stromal Tumors (GIST) Registry (NCT00507273) | M.D. Anderson Cancer Center | 2005-08-01 |
| Cancer Patients' Medication Knowledge in the Emergency Center (NCT00385476) | M.D. Anderson Cancer Center | 2005-08-01 |
| Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger (NCT00290498) | M.D. Anderson Cancer Center | 2005-08-01 |
| Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer (NCT02877056) | M.D. Anderson Cancer Center | 2005-08-01 |
| Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients (NCT00382590) | M.D. Anderson Cancer Center | 2005-08-01 |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin (NCT00147225) | M.D. Anderson Cancer Center | 2005-08-01 |
| Phase II 5-Azacytidine Plus VPA Plus ATRA (NCT00326170) | M.D. Anderson Cancer Center | 2005-07-01 |
| Effects of Rocking on Postoperative Ileus Duration Study (NCT00494806) | M.D. Anderson Cancer Center | 2005-07-01 |
| Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions (NCT00502580) | M.D. Anderson Cancer Center | 2005-07-01 |
| A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast (NCT00147238) | M.D. Anderson Cancer Center | 2005-07-01 |
| Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia (NCT00427791) | M.D. Anderson Cancer Center | 2005-07-01 |
| Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease (NCT00385788) | M.D. Anderson Cancer Center | 2005-07-01 |
| Delirium Recall in Advanced Cancer Patients (NCT00493714) | M.D. Anderson Cancer Center | 2005-07-01 |
| Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) (NCT00129740) | M.D. Anderson Cancer Center | 2005-06-27 |
| Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease (NCT00129753) | M.D. Anderson Cancer Center | 2005-06-22 |
| Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics (NCT01502150) | M.D. Anderson Cancer Center | 2005-06-16 |
| Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial (NCT00816114) | M.D. Anderson Cancer Center | 2005-06-08 |
| Ph II Study of Azacitidine in Myelofibrosis (NCT00569660) | M.D. Anderson Cancer Center | 2005-06-01 |
| IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome (NCT00469144) | M.D. Anderson Cancer Center | 2005-06-01 |
| Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan (NCT00496873) | M.D. Anderson Cancer Center | 2005-06-01 |
| Markers of Response to Intravesical Bladder Cancer Therapy (NCT01007058) | M.D. Anderson Cancer Center | 2005-06-01 |
| Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer (NCT00438477) | M.D. Anderson Cancer Center | 2005-06-01 |
| CFAR Study in Patients With Chronic Lymphocytic Leukemia (NCT00525603) | M.D. Anderson Cancer Center | 2005-06-01 |
| Subcutaneous Olanzapine for Hyperactive or Mixed Delirium (NCT00512291) | M.D. Anderson Cancer Center | 2005-06-01 |
| Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy (NCT00991094) | M.D. Anderson Cancer Center | 2005-05-27 |
| Phase I Trial of ZIO-101 in Patients With Solid Tumors (NCT00509782) | M.D. Anderson Cancer Center | 2005-05-01 |
| Physical Activity After Endometrial Cancer (NCT00501761) | M.D. Anderson Cancer Center | 2005-05-01 |
| Azacytidine and Valproic Acid in Patients With Advanced Cancers (NCT00496444) | M.D. Anderson Cancer Center | 2005-05-01 |
| Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome (NCT00806598) | M.D. Anderson Cancer Center | 2005-05-01 |
| Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer (NCT01076335) | M.D. Anderson Cancer Center | 2005-05-01 |
| Pegasys® in Patients With Myeloproliferative Diseases (NCT00452023) | M.D. Anderson Cancer Center | 2005-04-07 |
| Delayed-Immediate Breast Reconstruction (NCT00473122) | M.D. Anderson Cancer Center | 2005-04-01 |
| Targeted Intervention for Melanoma Prevention (NCT00394134) | M.D. Anderson Cancer Center | 2005-04-01 |
| Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer (NCT00113334) | M.D. Anderson Cancer Center | 2005-04-01 |
| The Collection and Storage of Umbilical Cord Blood for Transplantation (NCT01728545) | M.D. Anderson Cancer Center | 2005-04-01 |
| Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma (NCT00525915) | M.D. Anderson Cancer Center | 2005-04-01 |
| Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT00113347) | M.D. Anderson Cancer Center | 2005-04-01 |
| Group Therapy for Nicotine Dependence: Mindfulness and Smoking (NCT00297479) | M.D. Anderson Cancer Center | 2005-04-01 |
| Depression and Adherence in Head and Neck Cancer (NCT00498875) | M.D. Anderson Cancer Center | 2005-03-15 |
| FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years (NCT00254410) | M.D. Anderson Cancer Center | 2005-03-14 |
| Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure (NCT00113321) | M.D. Anderson Cancer Center | 2005-03-01 |
| Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies (NCT00472056) | M.D. Anderson Cancer Center | 2005-03-01 |
| Autologous Transplantation for Chronic Myelogenous Leukemia (NCT01003054) | M.D. Anderson Cancer Center | 2005-03-01 |
| Study of Atiprimod Treatment for Patients With Advanced Cancer (NCT00430014) | M.D. Anderson Cancer Center | 2005-03-01 |
| Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors (NCT00507884) | M.D. Anderson Cancer Center | 2005-03-01 |
| Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast (NCT00496808) | M.D. Anderson Cancer Center | 2005-03-01 |
| Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement (NCT00507962) | M.D. Anderson Cancer Center | 2005-03-01 |
| Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia (NCT00511615) | M.D. Anderson Cancer Center | 2005-03-01 |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer (NCT00388804) | M.D. Anderson Cancer Center | 2005-02-01 |
| Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma (NCT00113217) | M.D. Anderson Cancer Center | 2005-02-01 |
| Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer (NCT00113230) | M.D. Anderson Cancer Center | 2005-02-01 |
| 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT00102635) | M.D. Anderson Cancer Center | 2005-01-20 |
| Treatment of Resectable Malignant Brain Tumors (NCT00415467) | M.D. Anderson Cancer Center | 2005-01-01 |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients (NCT00500422) | M.D. Anderson Cancer Center | 2005-01-01 |
| Non-Myeloablative Allogeneic Stem Cell Transplantation (NCT00525876) | M.D. Anderson Cancer Center | 2005-01-01 |
| Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) (NCT01083589) | M.D. Anderson Cancer Center | 2005-01-01 |
| RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma (NCT00113360) | M.D. Anderson Cancer Center | 2005-01-01 |
| Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients (NCT00354978) | M.D. Anderson Cancer Center | 2005-01-01 |
| Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide (NCT00102648) | M.D. Anderson Cancer Center | 2004-12-21 |
| Psychosocial Impact of Cancer-Related Female Infertility (NCT00386217) | M.D. Anderson Cancer Center | 2004-12-01 |
| Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer (NCT00102622) | M.D. Anderson Cancer Center | 2004-12-01 |
| Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma (NCT00354523) | M.D. Anderson Cancer Center | 2004-12-01 |
| Quality of Friendships in Children With Neurofibromatosis (NCT00508235) | M.D. Anderson Cancer Center | 2004-12-01 |
| Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma (NCT00427765) | M.D. Anderson Cancer Center | 2004-12-01 |
| Respiratory Tumor and Normal Tissue Motion (NCT00415675) | M.D. Anderson Cancer Center | 2004-11-01 |
| Trial of Curcumin in Advanced Pancreatic Cancer (NCT00094445) | M.D. Anderson Cancer Center | 2004-11-01 |
| Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater (NCT00354887) | M.D. Anderson Cancer Center | 2004-11-01 |
| Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma (NCT00113841) | M.D. Anderson Cancer Center | 2004-11-01 |
| Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL (NCT00452374) | M.D. Anderson Cancer Center | 2004-11-01 |
| Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia (NCT00940342) | M.D. Anderson Cancer Center | 2004-10-12 |
| Spousal Relationships and Pain in Metastatic Breast Cancer (NCT00386620) | M.D. Anderson Cancer Center | 2004-10-01 |
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00317772) | M.D. Anderson Cancer Center | 2004-09-02 |
| Bone Response in Metastatic Breast Cancer Involving Bones (NCT00420433) | M.D. Anderson Cancer Center | 2004-09-01 |
| Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging (NCT00499382) | M.D. Anderson Cancer Center | 2004-09-01 |
| Alemtuzumab and Pentostatin In T-cell Neoplasms (NCT00453193) | M.D. Anderson Cancer Center | 2004-09-01 |
| Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia (NCT00509600) | M.D. Anderson Cancer Center | 2004-09-01 |
| Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290 (NCT02093546) | M.D. Anderson Cancer Center | 2004-08-13 |
| Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma (NCT00307710) | M.D. Anderson Cancer Center | 2004-08-01 |
| Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients (NCT00516269) | M.D. Anderson Cancer Center | 2004-08-01 |
| Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors (NCT00502892) | M.D. Anderson Cancer Center | 2004-08-01 |
| Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients (NCT00352391) | M.D. Anderson Cancer Center | 2004-08-01 |
| Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM (NCT00508456) | M.D. Anderson Cancer Center | 2004-08-01 |
| Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer (NCT00388154) | M.D. Anderson Cancer Center | 2004-08-01 |
| Quantitative Diffusion and Fat Imaging of the Spine (NCT00498277) | M.D. Anderson Cancer Center | 2004-08-01 |
| Taxotere/Temodar/Cisplatin Study in Melanoma Patients (NCT00527761) | M.D. Anderson Cancer Center | 2004-08-01 |
| A Mood Management Intervention for Pregnant Smokers (NCT00505869) | M.D. Anderson Cancer Center | 2004-08-01 |
| Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients (NCT00526110) | M.D. Anderson Cancer Center | 2004-08-01 |
| Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). (NCT00088218) | M.D. Anderson Cancer Center | 2004-07-01 |
| PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP (NCT00088231) | M.D. Anderson Cancer Center | 2004-07-01 |
| Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases (NCT00081159) | M.D. Anderson Cancer Center | 2004-07-01 |